| Therapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades? E Abdollahi, AA Momtazi, TP Johnston, A Sahebkar Journal of cellular physiology 233 (2), 830-848, 2018 | 294 | 2018 |
| Curcumin as a MicroRNA regulator in cancer: a review AA Momtazi, F Shahabipour, S Khatibi, TP Johnston, M Pirro, A Sahebkar Reviews of Physiology, Biochemistry and Pharmacology, Vol. 171, 1-38, 2016 | 253 | 2016 |
| Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, LE Simental-Mendía, M Majeed, ... Drug research 68 (07), 403-409, 2018 | 248 | 2018 |
| Curcumin: A natural modulator of immune cells in systemic lupus erythematosus AA Momtazi-Borojeni, SM Haftcheshmeh, SA Esmaeili, TP Johnston, ... Autoimmunity reviews 17 (2), 125-135, 2018 | 227 | 2018 |
| Isolation, identification, and characterization of cancer stem cells: A review MR Abbaszadegan, V Bagheri, MS Razavi, AA Momtazi, A Sahebkar, ... Journal of cellular physiology 232 (8), 2008-2018, 2017 | 226 | 2017 |
| Curcumin: a potentially powerful tool to reverse cisplatin-induced toxicity R Rezaee, AA Momtazi, A Monemi, A Sahebkar Pharmacological research 117, 218-227, 2017 | 196 | 2017 |
| Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease AS Moghaddam, JT Afshari, SA Esmaeili, E Saburi, Z Joneidi, ... Atherosclerosis 285, 1-9, 2019 | 188 | 2019 |
| A review on the pharmacology and toxicology of steviol glycosides extracted from Stevia rebaudiana A Abbas Momtazi-Borojeni, SA Esmaeili, E Abdollahi, A Sahebkar Current pharmaceutical design 23 (11), 1616-1622, 2017 | 187 | 2017 |
| Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases AA Momtazi, G Derosa, P Maffioli, M Banach, A Sahebkar Molecular diagnosis & therapy 20, 335-345, 2016 | 185 | 2016 |
| Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile A Abbas Momtazi, A Sahebkar Current pharmaceutical design 22 (28), 4386-4397, 2016 | 177 | 2016 |
| Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues R Vakili-Ghartavol, AA Momtazi-Borojeni, Z Vakili-Ghartavol, ... Artificial Cells, Nanomedicine, and Biotechnology 48 (1), 443-451, 2020 | 172 | 2020 |
| PCSK9 and inflammation: a review of experimental and clinical evidence AA Momtazi-Borojeni, S Sabouri-Rad, AM Gotto Jr, M Pirro, M Banach, ... European Heart Journal-Cardiovascular Pharmacotherapy 5 (4), 237-245, 2019 | 167 | 2019 |
| Regulation of PCSK9 by nutraceuticals AA Momtazi, M Banach, M Pirro, N Katsiki, A Sahebkar Pharmacological research 120, 157-169, 2017 | 131 | 2017 |
| The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials L Ansari, F Shiehzadeh, Z Taherzadeh, S Nikoofal-Sahlabadi, ... Cancer gene therapy 24 (5), 189-193, 2017 | 128 | 2017 |
| Anti‐inflammatory and immune‐modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation SM Ehteshamfar, M Akhbari, JT Afshari, M Seyedi, B Nikfar, ... Journal of cellular and molecular medicine 24 (23), 13573-13588, 2020 | 115 | 2020 |
| Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1 Z Yin, M Yu, T Ma, C Zhang, S Huang, MR Karimzadeh, ... Journal for immunotherapy of cancer 9 (1), e001698, 2021 | 113 | 2021 |
| A novel Schiff base derived from the gabapentin drug and copper (II) complex: Synthesis, characterization, interaction with DNA/protein and cytotoxic activity Z Shokohi-Pour, H Chiniforoshan, AA Momtazi-Borojeni, B Notash Journal of Photochemistry and Photobiology B: Biology 162, 34-44, 2016 | 108 | 2016 |
| Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy AA Momtazi-Borojeni, E Abdollahi, B Nikfar, S Chaichian, ... Heart failure reviews 24 (3), 399-409, 2019 | 102 | 2019 |
| Regulatory effects of berberine on microRNome in cancer and other conditions SH Ayati, B Fazeli, AA Momtazi-Borojeni, AFG Cicero, M Pirro, ... Critical reviews in oncology/hematology 116, 147-158, 2017 | 97 | 2017 |
| Altered expression of microRNAs in rheumatoid arthritis F Tavasolian, E Abdollahi, R Rezaei, AA Momtazi‐borojeni, Y Henrotin, ... Journal of cellular biochemistry 119 (1), 478-487, 2018 | 95 | 2018 |
Amirhossein SahebkarMashhad University of Medical SciencesBestätigte E-Mail-Adresse bei mums.ac.ir
